20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Solventum Corp. (SOLV) operates in the Health Care Technology industry and is headquartered in Eagan, United States with about 20,584 employees. Its market capitalization is roughly $14 billion. In the fiscal year ended 2025-12-31, SOLV reported $8.3B in revenue and $1.6B in net income.
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Interactive charts & full statements → Open the SOLV valuation workbench →
| Income statement | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | $8.3B | $8.3B | $8.3B | $8.2B | $8.1B | $8.2B | $7.3B |
| Gross Profit | $4.4B | $4.5B | $4.6B | $4.7B | $4.7B | $4.9B | $4.3B |
| Gross Margin % | 53.7% | 53.5% | 55.6% | 57.2% | 57.8% | 60.2% | 59.3% |
| Operating Income (EBIT) | $2.1B | $2.2B | $1.0B | $1.7B | $1.7B | $1.9B | $1.4B |
| Operating Margin % | 25.5% | 26.2% | 12.6% | 20.6% | 20.8% | 23.0% | 19.6% |
| Net Income | $1.4B | $1.6B | $479M | $1.3B | $1.3B | $1.5B | $1.1B |
| Net Margin % | 17.3% | 18.7% | 5.8% | 16.4% | 16.5% | 17.9% | 15.6% |
| EBITDA | $2.8B | $2.5B | $1.5B | $2.2B | $2.3B | $2.5B | $2.0B |
| Earnings Per Share (EPS) | $8.16 | $8.88 | $2.76 | $7.79 | $7.79 | $8.47 | $6.60 |
| Shares Outstanding (M) | 176M | 175M | 174M | 173M | 172M | 172M | 172M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.0B | $2.0B | $2.1B | $2.2B | $2.1B | $2.1B | $2.1B | $2.1B |
| Gross Profit | $1.1B | $985M | $1.2B | $1.2B | $1.1B | $1.1B | $1.2B | $1.1B |
| Gross Margin % | 54.7% | 49.3% | 56.1% | 54.4% | 53.8% | 53.9% | 56.0% | 54.6% |
| Operating Income (EBIT) | $81M | $1.7B | $137M | $214M | $152M | $136M | $275M | $244M |
| Operating Margin % | 4.0% | 84.0% | 6.5% | 9.9% | 7.3% | 6.6% | 13.2% | 11.7% |
| Net Income | $13M | $63M | $1.3B | $90M | $137M | $31M | $122M | $89M |
| Net Margin % | 0.7% | 3.1% | 60.4% | 4.2% | 6.6% | 1.5% | 5.9% | 4.3% |
| EBITDA | $213M | $489M | $1.7B | $328M | $271M | $270M | $407M | $343M |
| Earnings Per Share (EPS) | $0.07 | $0.36 | $7.22 | $0.51 | $0.78 | $0.18 | $0.70 | $0.51 |
| Shares Outstanding (M) | 176M | 175M | 175M | 175M | 175M | 174M | 174M | 174M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $151M | $369M | $1.2B | $1.9B | $1.7B | $2.2B | $2.0B |
| Capital Expenditures (CapEx) | $354M | $379M | $380M | $290M | $251M | $277M | $271M |
| Free Cash Flow (FCF) | ($203M) | ($10M) | $805M | $1.6B | $1.4B | $1.9B | $1.8B |
| FCF Margin % | -2.5% | -0.1% | 9.8% | 19.8% | 17.6% | 23.6% | 24.1% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($189M) | $95M | $76M | $169M | $29M | $219M | $169M | $355M |
| Capital Expenditures (CapEx) | $84M | $63M | $97M | $110M | $109M | $127M | $93M | $58M |
| Free Cash Flow (FCF) | ($273M) | $32M | ($21M) | $59M | ($80M) | $92M | $76M | $297M |
| FCF Margin % | -13.6% | 1.6% | -1.0% | 2.7% | -3.9% | 4.4% | 3.6% | 14.3% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Total Assets | $14.1B | $14.3B | $14.5B | $13.9B | $13.6B | $14.1B |
| Cash & Cash Equivalents | $561M | $878M | $762M | $194M | $61M | $91M |
| Total Liabilities | $9.1B | $9.2B | $11.5B | $2.3B | $1.9B | $2.0B |
| Total Debt (Short + Long-Term) | $5.1B | $5.0B | $8.0B | $8.3B | $27M | $29M |
| Total Shareholders' Equity | $5.0B | $5.0B | $3.0B | $11.7B | $11.7B | $12.1B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SOLV viewer.
About TickerBase · Data methodology & sources